Sign inJoin waitlistJoin the waitlist

Marta Crispens

Chair and Professor, Obstetrics and Gynecology · University of Arizona College of Medicine-Tucson

Credentials: · · · · · ·

History

Obstetrics and Gynecology Department · University of Arizona College of Medicine-Tucson
Present
Obstetrics and Gynecology Department · University of Arizona College of Medicine-Tucson
Present
University of Arizona College of Medicine-Tucson
Present

Healthcare Management, Western Governors University, 2019
2019
Gynecologic Oncology
University of Texas M D Anderson Cancer Center
1995–1998
University of Alabama at Birmingham
1991–1995
University of Alabama at Birmingham School of Medicine
1987–1991
Biology, Emory University, 1987
1987

Research

Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2019 · 840 citations
Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2018 · 505 citations
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2023 · 486 citations

Dineo Khabele
20 papers
NA
Nadeem Abu-Rustum
18 papers
Susana Campos
18 papers
David Gaffney
17 papers
David Mutch
17 papers
SR
Steven Remmenga
16 papers
Christine Fisher
14 papers
Peter Frederick
14 papers
Andrea Mariani
13 papers
Hye Chon
12 papers
Larissa Nekhlyudov
12 papers
OF
Oluwole Fadare
12 papers

Grants

Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $1.8M · Vanderbilt University Medical Center
1997–2025

Clinical trials

Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers
Principal investigator · Terminated · Phase 1
Vanderbilt-Ingram Cancer Center
2020–2022
PET Imaging of Ovarian Carcinoma With 18F-FSPG
Principal investigator · Withdrawn · Early phase 1
Vanderbilt-Ingram Cancer Center
2018–2020
SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin
Principal investigator · Terminated · Phase 2
National Cancer Institute (NCI)
2010–2013
Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer
Principal investigator · Completed
Vanderbilt-Ingram Cancer Center
2006–2008